These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29704309)

  • 1. The neuroprotective and antidepressant-like effects of Hcyb1, a novel selective PDE2 inhibitor.
    Liu L; Zheng J; Huang XF; Zhu X; Ding SM; Ke HM; O'Donnell JM; Zhang HT; Song GQ; Xu Y
    CNS Neurosci Ther; 2018 Jul; 24(7):652-660. PubMed ID: 29704309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase 2 inhibitor Hcyb1 reverses corticosterone-induced neurotoxicity and depression-like behavior.
    Zhu MJ; Shi J; Chen Y; Huang G; Zhu XW; Zhang S; Huang XF; Song GQ; Zhang HT; Ke HM; O'Donnell JM; Wang LQ; Xu Y
    Psychopharmacology (Berl); 2020 Nov; 237(11):3215-3224. PubMed ID: 32926224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of 2 Novel Phosphodiesterase 2 Inhibitors Hcyb1 and PF-05180999 on Depression- and Anxiety-Like Behavior.
    Yan Y; Zhao Y; Lu Y; Acharya AP; Wang W; Zhan CG; Ye J; Du F; Zhu X; Xu Y
    Int J Neuropsychopharmacol; 2023 Jun; 26(6):415-425. PubMed ID: 37208298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel PDE9 inhibitor WYQ-C36D ameliorates corticosterone-induced neurotoxicity and depression-like behaviors by cGMP-CREB-related signaling.
    Huang XF; Jiang WT; Liu L; Song FC; Zhu X; Shi GL; Ding SM; Ke HM; Wang W; O'Donnell JM; Zhang HT; Luo HB; Wan YQ; Song GQ; Xu Y
    CNS Neurosci Ther; 2018 Oct; 24(10):889-896. PubMed ID: 29722134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant-like effects of the phosphodiesterase-4 inhibitor etazolate and phosphodiesterase-5 inhibitor sildenafil via cyclic AMP or cyclic GMP signaling in mice.
    Wang C; Zhang J; Lu Y; Lin P; Pan T; Zhao X; Liu A; Wang Q; Zhou W; Zhang HT
    Metab Brain Dis; 2014 Sep; 29(3):673-82. PubMed ID: 24705918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase-2 inhibitor reverses post-traumatic stress induced fear memory deficits and behavioral changes via cAMP/cGMP pathway.
    Chen L; Liu K; Wang Y; Liu N; Yao M; Hu J; Wang G; Sun Y; Pan J
    Eur J Pharmacol; 2021 Jan; 891():173768. PubMed ID: 33271150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-like and neuroprotective effects of Aloysia gratissima: investigation of involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway.
    Zeni AL; Zomkowski AD; Dal-Cim T; Maraschin M; Rodrigues AL; Tasca CI
    J Ethnopharmacol; 2011 Sep; 137(1):864-74. PubMed ID: 21767626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The VGF-derived peptide TLQP62 produces antidepressant-like effects in mice via the BDNF/TrkB/CREB signaling pathway.
    Lin P; Wang C; Xu B; Gao S; Guo J; Zhao X; Huang H; Zhang J; Chen X; Wang Q; Zhou W
    Pharmacol Biochem Behav; 2014 May; 120():140-8. PubMed ID: 24631486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tropisetron and ondansetron in mice forced swimming test and tail suspension test.
    Haj-Mirzaian A; Kordjazy N; Amiri S; Haj-Mirzaian A; Amini-Khoei H; Ostadhadi S; Dehpour A
    Eur J Pharmacol; 2016 Jun; 780():71-81. PubMed ID: 27001377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase-2 inhibitor reverses corticosterone-induced neurotoxicity and related behavioural changes via cGMP/PKG dependent pathway.
    Xu Y; Pan J; Chen L; Zhang C; Sun J; Li J; Nguyen L; Nair N; Zhang H; O'Donnell JM
    Int J Neuropsychopharmacol; 2013 May; 16(4):835-47. PubMed ID: 22850435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2007 Aug; 569(1-2):77-83. PubMed ID: 17585901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etazolate abrogates the lipopolysaccharide (LPS)-induced downregulation of the cAMP/pCREB/BDNF signaling, neuroinflammatory response and depressive-like behavior in mice.
    Guo J; Lin P; Zhao X; Zhang J; Wei X; Wang Q; Wang C
    Neuroscience; 2014 Mar; 263():1-14. PubMed ID: 24434771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant-Like and Neuroprotective Effects of Ethanol Extract from the Root Bark of
    Kim YH; Im AR; Park BK; Paek SH; Choi G; Kim YR; Whang WK; Lee KH; Oh SE; Lee MY
    Biomed Res Int; 2018; 2018():7383869. PubMed ID: 30581865
    [No Abstract]   [Full Text] [Related]  

  • 14. The phosphodiesterase type 2 inhibitor BAY 60-7550 reverses functional impairments induced by brain ischemia by decreasing hippocampal neurodegeneration and enhancing hippocampal neuronal plasticity.
    Soares LM; Meyer E; Milani H; Steinbusch HW; Prickaerts J; de Oliveira RM
    Eur J Neurosci; 2017 Feb; 45(4):510-520. PubMed ID: 27813297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
    Suvarna NU; O'Donnell JM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3K/mTOR pathways.
    Bettio LE; Cunha MP; Budni J; Pazini FL; Oliveira Á; Colla AR; Rodrigues AL
    Behav Brain Res; 2012 Oct; 234(2):137-48. PubMed ID: 22743004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of bis selenide in the mouse tail suspension test.
    Jesse CR; Wilhelm EA; Bortolatto CF; Rocha JB; Nogueira CW
    Eur J Pharmacol; 2010 Jun; 635(1-3):135-41. PubMed ID: 20307533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydromyricetin exerts a rapid antidepressant-like effect in association with enhancement of BDNF expression and inhibition of neuroinflammation.
    Ren Z; Yan P; Zhu L; Yang H; Zhao Y; Kirby BP; Waddington JL; Zhen X
    Psychopharmacology (Berl); 2018 Jan; 235(1):233-244. PubMed ID: 29058041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid antidepressant-like effect of Fructus Aurantii depends on cAMP-response element binding protein/Brain-derived neurotrophic facto by mediating synaptic transmission.
    Wu L; Zhang T; Chen K; Lu C; Liu XF; Zhou JL; Huang YK; Yan H; Chen Y; Zhang CJ; Li JF; Shi SQ; Ren P; Huang X
    Phytother Res; 2021 Jan; 35(1):404-414. PubMed ID: 33044778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant-like Effects of ZBH2012001, a Novel Potent Serotonin and Norepinephrine Reuptake Inhibitor.
    Fan QY; Xue R; Li Y; Zhang TT; He XH; Fan SY; Li YF; Zhong BH; Zhang YZ; Li J
    CNS Neurosci Ther; 2016 Aug; 22(8):700-6. PubMed ID: 27207183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.